Many folks dream of early retirement, whether that means leaving the workforce in their late 40s, mid-50s, or early 60s. But taking that leap is far easier said than done.Read more
So far, Apple (NASDAQ:AAPL) has mostly been able to avoid the effects of President Trump’s trade war, as its products have been excluded from tariffs on Chinese imports. CEO Tim Cook is on relatively good terms with the White House, which likely contributed to the exclusions. Unfortunately for the global economy, the trade war continues to escalate, and Trump might include Apple with the next round.
Amazon.com (NASDAQ:AMZN) stock, currently priced at $1,512.29 per share, has gained 29.4% in 2018 through Monday, Nov. 19. That’s a darn good showing from the e-commerce and cloud-computing giant considering the S&P 500 and Nasdaq indices have returned 2.4% and 1.8%, respectively, over this period.
Although cryptocurrencies have had a miserable year, the technology underlying them, known as blockchain, may have staying power. In particular, blockchain technology offers the ability to transmit money in a secure manner without the need for traditional banking networks. It also allows for the transparent and immutable storage of data. In plain English, it could allow for quicker money transfers and provide use outside the banking industry with regard to data storage. Its utility both within and outside the financial sector is what makes blockchain so intriguing.
For better or worse, Social Security plays a vital role in keeping millions of people (mostly the elderly) out of poverty in this country. A recent update from the Center on Budget and Policy Priorities finds that 22.1 million people — that’s out of more than 62 million current beneficiaries — are single-handedly pushed out of poverty thanks to their monthly benefit check. This includes just over 15.3 million retired workers.
Tesla (NASDAQ:TSLA) took investors by surprise last month when the electric-car company swung from a loss to a meaningful profit. On a non-GAAP basis, Tesla earned $2.90 per share, crushing a consensus analyst estimate for non-GAAP EPS of just $0.17. GAAP earnings and free cash flow for the period were impressive, too. The company’s sudden profitability comes as Model 3 deliveries are surging.
The recent stock market sell-off has created opportunities, but it’s also increased risks, especially if you invest in high-flying industries such as biotech that can pop or drop significantly on any day because of clinical trial news. To help you find the best biotech stocks to buy now, we asked three Fool contributors for their best ideas now. There’s no telling what’s in store next for these companies, but they think Global Blood Therapeutics (NASDAQ:GBT), Supernus Pharmaceuticals (NASDAQ:SUPN), and bluebird bio (NASDAQ:BLUE) are top stocks that biotech investors ought to be adding to portfolios this month.
October had more tricks than treats for investors. The markets started clawing their way back during the final two days of the month, but some stocks have still dug themselves into pretty big holes. Many will stay there, but let’s size up the ones that should not.
Imagine that in the next few decades, vehicles will slowly evolve from machines that we are entirely in control of to ones that become artificially intelligent chauffeurs, tirelessly carting us around town day and night.
Want a high-growth stock but don’t want to deal with the exceptional volatility and concerns about business longevity that come with owning small-cap stocks? Then say hello to mid-cap stocks, which can offer the perfect blend of growth, value, and more established business models.